Puma Biotechnology, Inc. financial data

Symbol
PBYI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10880 Wilshire Blvd., Suite 2150, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
INNOVATIVE ACQUISITIONS CORP (to 10/4/2011)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 143 % -23.1%
Quick Ratio 6.74 % -23.7%
Debt-to-equity 225 % -51.1%
Return On Equity 46.1 % -20.8%
Return On Assets 14.2 % +36.6%
Operating Margin 13.4 % -3.03%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.6M shares +2.84%
Common Stock, Shares, Outstanding 49.1M shares +3.06%
Entity Public Float 134M USD -4.95%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.6M shares +3.21%
Weighted Average Number of Shares Outstanding, Diluted 49.1M shares +3.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 230M USD -2.19%
Costs and Expenses 200M USD -1.72%
Operating Income (Loss) 31M USD -5.13%
Nonoperating Income (Expense) -6.87M USD +31.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 24.1M USD +6.29%
Income Tax Expense (Benefit) -6.18M USD -670%
Net Income (Loss) Attributable to Parent 30.3M USD +40.2%
Earnings Per Share, Basic 0.62 USD/shares +34.8%
Earnings Per Share, Diluted 0.62 USD/shares +37.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.2M USD -18.2%
Marketable Securities, Current 31.7M USD +180%
Cash, Cash Equivalents, and Short-term Investments 86.8M USD +77.5%
Accounts Receivable, after Allowance for Credit Loss, Current 32M USD -33.1%
Inventory, Net 8.72M USD +23.2%
Other Assets, Current 91K USD -90%
Assets, Current 148M USD -5.46%
Deferred Income Tax Assets, Net 7.08M USD
Property, Plant and Equipment, Net 515K USD -39.8%
Operating Lease, Right-of-Use Asset 4.58M USD -41.2%
Assets 213M USD -7.46%
Accounts Payable, Current 5.51M USD -20%
Employee-related Liabilities, Current 4.37M USD -0.25%
Accrued Liabilities, Current 36.9M USD -30%
Liabilities, Current 96.1M USD -3.29%
Operating Lease, Liability, Noncurrent 1.49M USD -78.8%
Other Liabilities, Noncurrent 121K USD 0%
Liabilities 121M USD -31.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD
Retained Earnings (Accumulated Deficit) -1.31B USD +2.25%
Stockholders' Equity Attributable to Parent 92.1M USD +72.4%
Liabilities and Equity 213M USD -7.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.2M USD +326%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -19.1M USD -9.34%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49.1M shares +3.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.83M USD +47.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.91M USD 0%
Deferred Tax Assets, Valuation Allowance 343M USD -6.85%
Deferred Tax Assets, Gross 352M USD -5.34%
Operating Lease, Liability 7.03M USD -40.6%
Depreciation 400K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 30.3M USD +40.3%
Lessee, Operating Lease, Liability, to be Paid 7.49M USD -43.7%
Property, Plant and Equipment, Gross 8.38M USD -1.78%
Operating Lease, Liability, Current 5.54M USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD -74.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.98M USD +3.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 457K USD -68.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.51M USD -74.8%
Deferred Tax Assets, Operating Loss Carryforwards 232M USD -3.64%
Unrecognized Tax Benefits 3.05M USD +8.32%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.51M USD 0%
Operating Lease, Payments 1.58M USD +5.34%
Amortization of Intangible Assets 9.7M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 8.49M USD +177%
Share-based Payment Arrangement, Expense 8.25M USD -19.5%
Interest Expense 13.4M USD +9.29%